177 related articles for article (PubMed ID: 24016270)
1. A neutralization scFv antibody against IL-1β isolated from a NIPA-based bacterial display library.
Li T; Xu L; Ren G; Yin C; Zhou B; Ye X; Li Q; Li N; Li D
Curr Pharm Biotechnol; 2013; 14(6):571-81. PubMed ID: 24016270
[TBL] [Abstract][Full Text] [Related]
2. [Establishment of scFv antibody library screening technology based on flow cytometry].
Xu L; Ren G; Yin J; Tian H; Li D
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Jan; 29(1):65-8. PubMed ID: 23294720
[TBL] [Abstract][Full Text] [Related]
3. Construction of an anti-IL-1β scfv and TNFRI fusion protein and its therapeutic effect on RA mice model.
Kan F; Ren G; Guo M; Qi J; Zhang Y; Han Y; Zhang Y; Li D
Curr Pharm Biotechnol; 2014; 14(12):1048-61. PubMed ID: 24433504
[TBL] [Abstract][Full Text] [Related]
4. A neutralizing scFv antibody against infectious bursal disease virus screened by flow cytometry.
Zhou Y; Xie ZG
J Immunol Methods; 2015 Sep; 424():80-4. PubMed ID: 26003676
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological efficacy of anti-IL-1β scFv, Fab and full-length antibodies in treatment of rheumatoid arthritis.
Qi J; Ye X; Ren G; Kan F; Zhang Y; Guo M; Zhang Z; Li D
Mol Immunol; 2014 Feb; 57(2):59-65. PubMed ID: 24091292
[TBL] [Abstract][Full Text] [Related]
6. Screening scFv antibodies against infectious bursal disease virus by co-expression of antigen and antibody in the bacteria display system.
Guo X; Cao H; Wang Y; Liu Y; Chen Y; Wang N; Jiang S; Zhang S; Wu Q; Li T; Zhang Y; Zhou B; Yin J; Li D; Ren G
Vet Immunol Immunopathol; 2016 Nov; 180():45-52. PubMed ID: 27692095
[TBL] [Abstract][Full Text] [Related]
7. Selection of affinity-improved neutralizing human scFv against HBV PreS1 from CDR3 VH/VL mutant library.
Chen Y; Bai Y; Guo X; Wang W; Zheng Q; Wang F; Sun D; Li D; Ren G; Yin J
Biologicals; 2016 Jul; 44(4):271-275. PubMed ID: 27255707
[TBL] [Abstract][Full Text] [Related]
8. Tetanus Neurotoxin Neutralizing Antibodies Screened from a Human Immune scFv Antibody Phage Display Library.
Wang H; Yu R; Fang T; Yu T; Chi X; Zhang X; Liu S; Fu L; Yu C; Chen W
Toxins (Basel); 2016 Sep; 8(9):. PubMed ID: 27626445
[TBL] [Abstract][Full Text] [Related]
9. [Construction of anti-B7-H4-scFv library and screening and identification of anti-B7-H4-scFv].
Shao L; Xu C; Ji H; Mao W; Wang Y; Liu X; Zhu Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Sep; 32(9):1260-6. PubMed ID: 27609584
[TBL] [Abstract][Full Text] [Related]
10. Production in yeast of pseudotype virus-like particles harboring functionally active antibody fragments neutralizing the cytolytic activity of vaginolysin.
Pleckaityte M; Zvirbliene A; Sezaite I; Gedvilaite A
Microb Cell Fact; 2011 Dec; 10():109. PubMed ID: 22171920
[TBL] [Abstract][Full Text] [Related]
11. [Construction and panning of scFv phage display library against recombinant interleukin 4 receptor].
Yang G; Guo H; Liu X; He G; Tian W; Cai K; Wang P; Wang W
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Jun; 32(6):829-33. PubMed ID: 27371853
[TBL] [Abstract][Full Text] [Related]
12. [Construction of a phage antibody library and screening of anti-epidermal growth factor receptor variant III single chain antibody].
Han DG; Duan XY; Guo YM; Zhou Q; Wang QY; Yang GX
Nan Fang Yi Ke Da Xue Xue Bao; 2010 Jan; 30(1):25-9. PubMed ID: 20117977
[TBL] [Abstract][Full Text] [Related]
13. [Cloning and expression of human single-chain Fv antibody against A beta(1-42) peptide involved in Alzheimer disease].
Jia J; Liu Z; Zhao XM; Liang P
Zhonghua Bing Li Xue Za Zhi; 2008 Jun; 37(6):400-4. PubMed ID: 19031720
[TBL] [Abstract][Full Text] [Related]
14. Selection of single-chain variable fragment antibodies against fenitrothion by ribosome display.
Luo Y; Xia Y
Anal Biochem; 2012 Feb; 421(1):130-7. PubMed ID: 22138186
[TBL] [Abstract][Full Text] [Related]
15. [Establishment of bacteria display technology for Fab antibody library screening].
Xu LM; Yin CK; Ren GP; Tian H; Wang XQ; Ding LJ; Li DS
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Oct; 27(10):1090-3. PubMed ID: 21968310
[TBL] [Abstract][Full Text] [Related]
16. Construction of human nonimmune library and selection of scFvs against IL-33.
Yuan Q; Huang L; Wang X; Wu Y; Gao Y; Li C; Nian S
Appl Biochem Biotechnol; 2012 Jun; 167(3):498-509. PubMed ID: 22562552
[TBL] [Abstract][Full Text] [Related]
17. Selection of Vaccinia Virus-Neutralizing Antibody from a Phage-Display Human-Antibody Library.
Shin YW; Chang KH; Hong GW; Yeo SG; Jee Y; Kim JH; Oh MD; Cho DH; Kim SH
J Microbiol Biotechnol; 2019 Apr; 29(4):651-657. PubMed ID: 30856707
[TBL] [Abstract][Full Text] [Related]
18. Generation of recombinant single-chain antibodies neutralizing the cytolytic activity of vaginolysin, the main virulence factor of Gardnerella vaginalis.
Pleckaityte M; Mistiniene E; Lasickiene R; Zvirblis G; Zvirbliene A
BMC Biotechnol; 2011 Nov; 11():100. PubMed ID: 22047084
[TBL] [Abstract][Full Text] [Related]
19. High throughput screening of scFv antibodies against viral hemorrhagic septicaemia virus by flow cytometry.
Zhou Y; Xie ZG
J Virol Methods; 2015 Jul; 219():18-22. PubMed ID: 25813596
[TBL] [Abstract][Full Text] [Related]
20. Recombinant H22(scFv) blocks CD64 and prevents the capture of anti-TNF monoclonal antibody. A potential strategy to enhance anti-TNF therapy.
Hristodorov D; Mladenov R; Brehm H; Fischer R; Barth S; Thepen T
MAbs; 2014; 6(5):1283-9. PubMed ID: 25517313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
